The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback